Key Financial Data Of Reporting Company

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7601173

Concept As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
2021-04-01 to
2022-03-31
Key financial data of reporting company
Business results of reporting company
Net sales
56,607,000,000 JPY
Operating revenue
1,371,000,000 JPY
Ordinary profit (loss)
4,880,000,000 JPY
717,000,000 JPY
Profit (loss)
682,000,000 JPY
Share capital
1,197,000,000 JPY
Total number of issued shares
30,563,199 xbrli:shares
Net assets
40,695,000,000 JPY
48,892,000,000 JPY
Total assets
41,301,000,000 JPY
83,297,000,000 JPY
Net assets per share
1,443.94
1,734.80
Dividend paid per share
15.00
Interim dividend paid per share
7.00
Basic earnings (loss) per share
151.22
23.79
Diluted earnings per share
Equity-to-asset ratio
0.985 xbrli:pure
0.5870 xbrli:pure
Rate of return on equity
0.0877 xbrli:pure
0.0168 xbrli:pure
Price-earnings ratio
8.35 xbrli:pure
53.10 xbrli:pure
Payout ratio
0.336 xbrli:pure
Net cash provided by (used in) operating activities
2,842,000,000 JPY
Net cash provided by (used in) investing activities
6,743,000,000 JPY
Net cash provided by (used in) financing activities
-2,996,000,000 JPY
Cash and cash equivalents
17,103,000,000 JPY
Number of employees
649 xbrli:pure
74 xbrli:pure
80 xbrli:pure
48 xbrli:pure
74 xbrli:pure
777 xbrli:pure
Average number of temporary employees
75 xbrli:pure
16 xbrli:pure
10 xbrli:pure
101 xbrli:pure
Total shareholder return
xbrli:pure
Total return on share price index
xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.